Wells Fargo
NVCR icon

Wells Fargo’s NovoCure NVCR Stock Holding History

Wells Fargo’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,000
Closed -$367K – 7761
2022
Q4 		$367K Buy
+5,000
New +$376K ﹤0.01% 3837

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo's NVCR Position: Q2 2026 in Review

Wells Fargo reduced its NovoCure (NVCR) stake by 14% in Q2 2026, selling an estimated $6.4M and leaving 2,528,093 shares worth $38.3M. The position accounts for 0.01% of the portfolio, ranked #1208.

Wells Fargo first reported a position in NVCR in Q4 2015 and has held it in 43 quarters since. The position peaked at $197M in Q4 2020. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Wells Fargo held 2,528,093 shares of NovoCure worth $38.3M as of Q2 2026.
  • Wells Fargo sold 423,144 NovoCure shares in Q2 2026, an estimated $6.4M.
  • NovoCure made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #1208 holding.
  • Wells Fargo first reported a position in NovoCure in Q4 2015 and has held it in 43 quarters since.
  • Wells Fargo's NovoCure position peaked at $197M in Q4 2020.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.